Testimony & Briefings
Testimony of Dr. Diana Zuckerman, PhD at the Senate Special Committee on Aging Hearing on Medical Devices, April 13, 2011
Thank you for the privilege of testifying at this important hearing. I am president of the National Research Center for Women & Families, a think tank dedicated to improving the health of adults and children. I am also testifying on behalf of our Cancer Prevention and Treatment Fund. I was trained in epidemiology at Yale Med School, [...] | more
FDA Needs to Provide Breast Implant Patients and Physicians with Unreported Industry Data about Quality of Life, Connective Tissue Symptoms, Rupture Rates per Patient, and Other Complications
January 5, 2012 Dr. Jeffrey Shuren, Director Center for Devices and Radiological Health Food and Drug Administration Silver Spring, MD 20993 RE: FDA Needs to Provide Breast Implant Patients and Physicians with Unreported Industry Data about Quality of Life, Connective Tissue Symptoms, Rupture Rates per Patient, and Other Complications Dear Dr. Shuren: At the FDA Advisory Panel meetings in 2003 and 2005, FDA [...] | more
Testimony of Dana M. Casciotti, MPH, PhD, at the FDA advisory committee meeting on breast implants, August 31, 2011
Dana Casciotti, the public health research director of the Cancer Prevention and Treatment Fund testifies at an FDA advisory meeting on breast implants. | more
Dr. Diana Zuckerman, ph.D, testimony at FDA advisory meeting on breast implants, August 30-31, 2011
Cancer Prevention and Treatment Fund president, Dr. Diana Zuckerman, testifies at an FDA advisory meeting on breast implants. | more
Cancer Patients’ Testimony at the FDA Advisory Panel Meeting August 2011
At an FDA advisory panel meeting on breast implants in August, three cancer patients testified about their experiences. | more
Letter to House of Representatives in Opposition to H.R 1639
40 organizations including the Caner Prevention and Treatment signed onto this letter opposing the exemption of many cigars from FDA regulations. | more
Testimony of Diana Zuckerman, PhD, President of the Cancer Prevention and Treatment Fund, Before the FDA, June 28, 2011
National Research Center of Women & Families President Diana Zuckerman testifies at the FDA meeting on Avastin. | more
Statement of Brandel France de Bravo, MPH, Cancer Prevention and Treatment Fund, to the Pediatric Advisory Committee
December 7, 2010 | more
